ReviewInternational journal of nanomedicine2026
Biological Safety Analysis of Nanoparticles: Exploring Toxicity, Mechanisms, and Safety Factors for Pharmaceuticals.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: With the rapid advancement of nanotechnology, nanoparticles (NPs) have been widely applied in fields such as drug delivery, medical imaging, and disease therapy, owing to their unique physicochemical and biological properties. However, as NPs become increasingly prevalent in industrial production and daily life, the frequency and routes of human exposure have significantly increased, making the safety issues arising from their interactions with biological systems a major focus of public health concern. Methods: This review systematically retrieved relevant literature from databases including PubMed and Web of Science over the past 15 years, focusing on toxicological studies of NPs at the organ and system levels. Results: It summarizes the key mechanisms of nanotoxicity and the critical factors influencing safety evaluation. The findings indicate that NPs toxicity primarily targets the liver, kidneys, nervous system, and immune system. Oxidative stress, inflammatory responses, and DNA damage represent the major common mechanisms of nanotoxicity, while physicochemical properties such as particle size, surface charge, and protein corona formation are the core factors affecting safety. Conclusion: Based on these findings, this review analyzes the limitations of existing research in the context of the current research landscape, aiming to provide theoretical support for the safe application of NPs and to offer a reference for the establishment of a systematic nanotoxicity safety evaluation framework.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.